Rubric Capital Management LP Heron Therapeutics, Inc. Transaction History
Rubric Capital Management LP
- $3.59 Billion
- Q3 2024
A detailed history of Rubric Capital Management LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 26,713,503 shares of HRTX stock, worth $42.7 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
26,713,503
Previous 26,713,503
-0.0%
Holding current value
$42.7 Million
Previous $93.5 Million
43.14%
% of portfolio
1.48%
Previous 2.77%
Shares
11 transactions
Others Institutions Holding HRTX
# of Institutions
179Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$14.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$13.3 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$11.2 Million28.8% of portfolio
-
Tejara Capital LTD London, X05.31MShares$8.49 Million5.03% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $190M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...